Cipher Gene Scores ￥100 Million in Series B Financing

(VCBeat) May. 11, 2021 -- Cipher Gene recently announced the closing of Series B financing of more than 100 million yuan, led by Tsinghua Innovation Ventures, with participation from new investors including TusStar and Yuanhui Venture Capital joining the existing groups of Chengshu Capital and Sova Capital. The proceeds from this round will be mainly used for clinical development and registration of products, market expansion and team construction.

Previously, Cipher Gene has completed angel round, Series A, A+ and Pre-B round of financing successively in 2016, 2018, 2019 and 2020. The company basically maintains the financing speed of once a year, which is highly recognized by the capital market.

Established in October 2015, Cipher Gene is an innovative company dedicated to building a data-driven platform for the precise diagnosis and treatment of children's genetic diseases.

Since 2016, when Cipher Gene fully focused on the field of childhood genetic diseases, the company has been well known in the industry for its whole-exome sequencing. The company uses the whole whole-exome sequencing technology to assist doctors in the accurate diagnosis of hereditary neurological disorders in children such as epilepsy. At present, it has also extended the indications for sequencing to the field of genetic or rare diseases in children.

Tsinghua Innovation Ventures is a scientific achievement industrialization investment management company under the Beijing Tsinghua Industrial Development Research Institute. It is committed to promoting the commercialization of Tsinghua University's major scientific and technological achievements. The company has invested more than 60 projects in total.

Founded in 1999 and headquartered in Beijing, China, TusStar is an investment firm that integrates innovation services and building business platforms. The company has incubated over 5000 firms, among which are excellent companies, including 49 Diamond Companies, 45 Golden Seed Project companies, and 34 listed companies as well as great entrepreneurs including 81 leading talents from RecruitmentProgram of Global Experts, Overseas Talent Pooling Program, and High-end Leading Talent Pooling Program.